Víctor Albarrán Jesús Chamorro Javier Pozas María San Román Diana Isabel Rosero Cristina Saavedra María Gion Alfonso Cortés Elena Escalera Eva Guerra Elena López Miranda María Fernández Abad Noelia Martínez Jañez
10.3389/fonc.2023.1158981
Front Oncol
2023 May 5;13:1158981.
brca parp inhibitors breast cancer germline olaparib talazoparib
CC BY
https://pubmed.ncbi.nlm.nih.gov/37213307/
Case Reports
PMC10196382
37213307
Maintained complete response to talazoparib in a BRCA-2 mutated metastatic luminal breast cancer: case report and review of literature
2023